Highbridge Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-7,351
| Closed | -$397K | – | 217 |
|
|
2019
Q1 | $397K | Sell |
7,351
-30,438
| -81% | -$1.64M | 0.01% | 242 |
|
|
2018
Q4 | $1.63M | Buy |
37,789
+13,784
| +57% | +$596K | 0.05% | 171 |
|
|
2018
Q3 | $1.41M | Buy |
24,005
+9,574
| +66% | +$561K | 0.03% | 293 |
|
|
2018
Q2 | $765K | Buy |
+14,431
| New | +$765K | 0.02% | 402 |
|
|
2016
Q4 | – | Sell |
-1,023
| Closed | -$274K | – | 1207 |
|
|
2016
Q3 | $274K | Buy |
+1,023
| New | +$274K | ﹤0.01% | 847 |
|
|
2015
Q4 | – | Sell |
-1,419
| Closed | -$399K | – | 1021 |
|
|
2015
Q3 | $399K | Buy |
+1,419
| New | +$399K | 0.01% | 673 |
|